EUVIMEDEUVIMED entdecken
Crossref

L26/P-088 Evaluating X-linked conditions in male preconception screening: a retrospective study of expanded carrier screening in sperm donors

J. Park, K. McWilliams, K. Baldwin

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.424 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von J. Park und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question What personal and reproductive risks are identified when healthy males undergo carrier screening for X-linked conditions and how do findings affect donor program suitability? Summary answer Including X-linked conditions in preconception screening can uncover clinically significant results in unsuspecting healthy sperm donor applicants, revealing health risks for themselves and future generations. What is known already Carrier screening for X-linked conditions currently focuses on female carriers at risk of having affected sons.1 Hemizygous males are traditionally excluded from X-linked screening on pan-ethnic panels as they are expected to exhibit disease, resulting in at-risk X-linked findings going unnoticed in clinically healthy males, despite their clear reproductive implications. This gap is especially significant in sperm donor populations, where unrecognized X-linked variants pose reproductive risks and may or may not affect donor suitability. Broadening male carrier screening to include X-linked conditions can improve risk detection, support informed reproductive decision-making, and reduce disease transmission in the donor-conceived population. Study design, size, duration A retrospective review of expanded carrier screening (ECS) results performed June 2023 – January 2026 on sperm donor applicants at a US sperm bank was performed. Results were reviewed to record the prevalence of X-linked findings and to calculate positivity rates. For each positive result, assessments of personal and reproductive risk and implications for donor suitability, in line with ASRM guidelines, were also noted. Participants/materials, setting, methods Sperm donor applicants aged 19-39 from a large U.S. sperm bank were included. Two ECS panels within the same commercial laboratory, one with 445 genes (38 X-linked), and one with 611 genes (46 X-linked), were evaluated. Positive results were determined by laboratory reporting of pathogenic, likely pathogenic, and intermediate alleles, with variants of uncertain significance excluded. Positive results were analyzed and positivity rates calculated by number of positives / total number of results x 100. Main results and the role of chance A total of 1170 sperm donor applicants underwent ECS; 904 (77.27%) completed the 445-gene panel and 266 (22.73%) the 611-gene panel. Overall, 64 (5.47%) had X-linked findings: 33 (2.8%) hemizygous for G6PD, 21 (1.80%) for FMR1, 9 (0.77%) for AFF2 intermediate alleles, and 1 (0.09%) for DMD. Among FMR1 findings, 17 were intermediate alleles and 4 were premutation alleles. All four X-linked conditions identified were included on both screening panels. Applicants with DMD or FMR1 premutation results were excluded from the donor program given increased personal and reproductive risks for Duchenne/Becker muscular dystrophy and FMR1-associated disorders, respectively. Notably, none of these applicants reported personal or family histories consistent with their results. Applicants with AFF2 intermediate, G6PD, and FMR1 intermediate findings were clinically asymptomatic, consistent with expectations for hemizygous males.2 Because AFF2 and FMR1 intermediate alleles carry low expansion risk in males, and G6PD deficiency is typically mild with no substantial increase in morbidity or mortality, these findings did not warrant donor exclusion. Overall, X-linked findings occurred more often than expected in this healthy male population, although most posed minimal personal or reproductive risk. Their identification nonetheless informed donor-suitability decisions, reducing significant risk for DMD and FMR1-associated disorders in donor-conceived persons. Limitations, reasons for caution Although the cohort is large, X-linked findings were rare, limiting statistical power and preventing meaningful comparison to population prevalence. Additionally, the 611-gene panel included 8 X-linked genes not on the 445-gene panel, creating variability in condition detection and possibly affecting observed yield. Wider implications of the findings X-linked findings in healthy men reveal gaps in male carrier screening and highlight the need to include X-linked conditions on preconception ECS panels. In donor programs, genetic expertise is essential to interpret results, assess risks, reduce X-linked disease transmission in donor-conceived persons, and facilitate informed decision making. Trial registration number No

Zitieren

APA

Park, J., McWilliams, K., & Baldwin, K. (2026). L26/P-088 Evaluating X-linked conditions in male preconception screening: a retrospective study of expanded carrier screening in sperm donors. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.424

Vancouver

Park J, McWilliams K, Baldwin K. L26/P-088 Evaluating X-linked conditions in male preconception screening: a retrospective study of expanded carrier screening in sperm donors. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.424

BibTeX
@article{Park2026,
  author = {Park, J. and McWilliams, K. and Baldwin, K.},
  title = {L26/P-088 Evaluating X-linked conditions in male preconception screening: a retrospective study of expanded carrier screening in sperm donors},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.424}
}
Kostenlos starten →